So Apparently Some Swiss Company Found Out That Brazilian Blood Has More Immunoglobulin (which Is Used

So apparently some Swiss company found out that Brazilian blood has more immunoglobulin (which is used in some medications made by pharma companies) than European blood, and now international pharma companies are lobbying to change Brazilian law to allow them to use our blood as a resource

There is no current evidence that those things are related, but it just so happens that at the same time there is also another law being discussed that would get rid of "bureaucracy" when it comes to ethics analyses of trials on humans. It would also remove the right, which all brazilians currently have, to access to the medication resulting from the trials they participated in

Both sources are in Portuguese because both news have been recently broke by a Brazilian investigative news agency, but if you don't speak it, you can always use automatic translation

I know there's a lot of fucked up shit happening in the world right now, but please pay attention to medical rights in Brasil right now. Especially if you're European, because virtually every company related to this is from your continent and plans to benefit you above all

ETA: using blood as a resource for these medications is not new; however, current law in brasil only allows that use to come from donated blood (because it comes from the plasma and apparently not all of it is used in blood transfusion; I'm not a doctor so I'm not clear on the details but that's the gist of it) and to be processed and used by Hemobrás, the State-owned company that handles this type of medical technology. The new law would allow for private companies to buy our blood from blood banks for their use. It is worth noting that at least one company has already explicitly stated that they won't be making the resulting medication available in the Brazilian market, so, essentially, they will be taking blood Brazilians donated to help other Brazilians and using it to treat immunocompromised Europeans, to the detriment of immunocompromised Brazilians that need the medicine. In the process, they will be making it harder for our State-owned company to use that same blood, forcing us to import from them and therefore making the medication more expensive. They also want to make it possible for Brazilians to sell their own blood - a deeply ethically questionable practice that is discouraged by the WHO and that has led to HIV outbreaks in Brasil in the past